1. Home
  2. ANL vs ABR Comparison

ANL vs ABR Comparison

Compare ANL & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$15.11

Market Cap

998.8M

Sector

N/A

ML Signal

HOLD

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$3.43

Market Cap

809.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANL
ABR
Founded
2004
2003
Country
Singapore
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
998.8M
809.7M
IPO Year
2022
2003

Fundamental Metrics

Financial Performance
Metric
ANL
ABR
Price
$15.11
$3.43
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
★ $29.50
$5.17
AVG Volume (30 Days)
143.5K
★ 4.8M
Earning Date
08-14-2026
10-30-2026
Dividend Yield
N/A
★ 19.10%
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$243.83
N/A
Revenue Next Year
N/A
$3.27
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$3.63
52 Week High
$17.25
$12.36

Technical Indicators

Market Signals
Indicator
ANL
ABR
Relative Strength Index (RSI) 50.08 15.79
Support Level $14.70 N/A
Resistance Level $15.29 $5.41
Average True Range (ATR) 1.02 0.17
MACD -0.11 -0.08
Stochastic Oscillator 29.50 2.00

Price Performance

Historical Comparison
ANL
ABR

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

Share on Social Networks: